MARAVAI LIFESCIENCES HOLDINGS, INC. Quarterly Interest Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q3 2024.
  • Maravai Lifesciences Holdings, Inc. Interest Expense for the quarter ending September 30, 2024 was $13.6M, a 17.2% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. Interest Expense for the twelve months ending September 30, 2024 was $51.8M, a 27.5% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Interest Expense for 2023 was $45.9M, a 125% increase from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Interest Expense for 2022 was $20.4M, a 32.5% decline from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Interest Expense for 2021 was $30.3M, a 1.56% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $51.8M $13.6M +$2M +17.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $49.8M $11.9M +$4.92M +70% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $44.9M $10.9M -$969K -8.19% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $45.9M $15.4M +$5.22M +51.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $40.7M $11.6M +$8.5M +271% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $32.2M $7.02M +$2.59M +58.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $29.6M $11.8M +$9.17M +344% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $20.4M $10.2M +$3.16M +45% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $17.3M $3.14M -$4.55M -59.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $21.8M $4.43M -$3.22M -42% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $25M $2.66M -$5.24M -66.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $30.3M $7.02M -$1.78M -20.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $32M $7.69M +$596K +8.41% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $31.4M $7.65M +$186K +2.49% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $31.3M $7.9M +$522K +7.07% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $30.7M $8.81M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $7.09M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $7.46M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $7.38M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.